1. Home
  2. ALUR vs PRPO Comparison

ALUR vs PRPO Comparison

Compare ALUR & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALUR
  • PRPO
  • Stock Information
  • Founded
  • ALUR 2009
  • PRPO N/A
  • Country
  • ALUR United States
  • PRPO United States
  • Employees
  • ALUR N/A
  • PRPO N/A
  • Industry
  • ALUR
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • ALUR
  • PRPO Industrials
  • Exchange
  • ALUR Nasdaq
  • PRPO Nasdaq
  • Market Cap
  • ALUR 18.0M
  • PRPO 17.1M
  • IPO Year
  • ALUR N/A
  • PRPO N/A
  • Fundamental
  • Price
  • ALUR $3.02
  • PRPO $14.70
  • Analyst Decision
  • ALUR Strong Buy
  • PRPO
  • Analyst Count
  • ALUR 3
  • PRPO 0
  • Target Price
  • ALUR $22.83
  • PRPO N/A
  • AVG Volume (30 Days)
  • ALUR 213.4K
  • PRPO 19.1K
  • Earning Date
  • ALUR 08-12-2025
  • PRPO 08-12-2025
  • Dividend Yield
  • ALUR N/A
  • PRPO N/A
  • EPS Growth
  • ALUR N/A
  • PRPO N/A
  • EPS
  • ALUR N/A
  • PRPO N/A
  • Revenue
  • ALUR $28,304,000.00
  • PRPO $20,029,000.00
  • Revenue This Year
  • ALUR N/A
  • PRPO N/A
  • Revenue Next Year
  • ALUR $49.37
  • PRPO N/A
  • P/E Ratio
  • ALUR N/A
  • PRPO N/A
  • Revenue Growth
  • ALUR N/A
  • PRPO 26.67
  • 52 Week Low
  • ALUR $2.15
  • PRPO $3.90
  • 52 Week High
  • ALUR $22.63
  • PRPO $16.89
  • Technical
  • Relative Strength Index (RSI)
  • ALUR 55.72
  • PRPO 61.14
  • Support Level
  • ALUR $3.05
  • PRPO $13.02
  • Resistance Level
  • ALUR $3.33
  • PRPO $14.74
  • Average True Range (ATR)
  • ALUR 0.23
  • PRPO 1.15
  • MACD
  • ALUR 0.02
  • PRPO -0.16
  • Stochastic Oscillator
  • ALUR 63.49
  • PRPO 43.41

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: